1 Karrison, T, Ferguson, D & Meier, P (1999) Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91, 80–85.
2 Mafune, KI & Tanaka, Y (2000) Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer. Ann Surg Oncol 7, 609–616.
3 Solomayer, EF, Feuerer, M & Bai, L (2003) Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res 9, 174–180.
4 Mccoy, JL, Rucker, R & Petros, JA (2000) Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade, or lymph node status. Breast Cancer Res 60, 227–234.
5 Von Mensdorrl-Pouilly, S, Verstraeten, AA, Kenemans, P, et al. (2000) Survival in early breast cancer patients is favourably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 18, 547–582.
6 Tagliaferri, M, Cohen, I & Tripathy, D (2001) Complementary and alternative medicine in early stage breast cancer. Semin Oncol 28, 121–134.
7 Newman, V, Rock, C & Faerber, S (1998) Dietary supplement use by women at risk for breast cancer recurrence: the Women's Healthy Eating and Living Study Group. J Am Diet Assoc 98, 285–292.
8 Von Gruenigen, V, White, L & Kirven, M (2001) A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 11, 205–209.
9 Wasser, SP & Weis, AL (1999) Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19, 65–96.
10 Wang, ZT, Ng, TB, Yeung, HW, et al. (1996) Immunomodulatory effect of a polysaccharide-enriched preparation of Codonopsis pilosula roots. Gen Pharmacol 27, 1347–1350.
11 Hardy, ML (2000) Herbs of special interest to women. J Am Pharm Assoc 40, 234–242.
12 Bradley, RR, Cunniff, PJ & Pereira, BJ (1999) Hematopoietic effect of Radix Angelicae sinensis in a hemodialysis patient. Am J Kidney Dis 34, 349–354.
13 Sun, W, Xu, Z & Wang, C (2005) Study on antioxidant activity of essential oils and its monomer from Pelargonium graveolens. Zhong Yao Cai 28, 87–89.
14 Tong, AW, Seamour, B, Lawson, JM, et al. (2000) Cellular immune profile of patients with advanced cancer before and after taxane treatment. Am J Clin Oncol 23, 463–472.
15 Gan, KH, Fann, YF, Hsu, SH, et al. (1998) Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J Nat Prod 61, 485–487.
16 Jinn, TR, Wu, CM, Tu, WC, et al. (2006) Functional expression of FIBP-gts, a fungal immunomodulatory protein from Ganoderma tsugae in Sf21 insect cells. Biosci Biotechnol Biochem 70, 2627–2634.
17 Kino, K, Yamashita, A & Yamaoka, K (1989) Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J Biol Chem 264, 472–478.
18 Ko, JL, Hsu, CI, Lin, RH, et al. (1995) A new fungal immunomodulatory protein, FIP-fve isolated from the edible mushroom, Flammulina velutipes, and its complete amino acid sequence. Eur J Biochem 228, 244–249.
19 Hsu, HC, Hsu, CI, Lin, RH, et al. (1997) Fip-vvo, a new fungal immunomodulatory protein isolated from Volvariella volvacea. Biochem J 323, 557–565.
20 Lin, WH, Hung, CH, Hsu, CI, et al. (1997) Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem 272, 20044–20048.
21 Anonymous (2002) Creating a neutropenia risk model that really works. ADVANCE Awareness Neutropenia Chermother 1, 1–6.
22 Balducci, L & Yates, J (2000) General guidelines for the management of older adults with cancer. Oncology 14, 221–227.
23 Herberman, RB & Ortaldo, JR (1981) Natural killer cells: their role in defense against disease. Science 214, 24–30.
24 Minato, N, Bloom, BR, Jones, C, et al. (1979) Mechanism of rejection of virus persistently infected tumor cells by athymic mice. J Exp Med 149, 1117–1133.
25 Locke, S, Kraus, L, Leserman, J, et al. (1984) Life change stress, psychiatric symptoms and natural killer cell activity. Psychosom Med 46, 441–453.
26 Brittenden, J, Heys, S, Ross, J, et al. (1996) Natural killer cells and cancer. Cancer 77, 1226–1243.
27 Levy, S, Herberman, R, Lippman, M, et al. (1991) Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med 17, 67–75.
28 Won, SJ, Lin, MT & Wu, WL (1992) Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice. Jpn J Pharmacol 59, 171–176.
29 Hakim, FTR, Cepeda, S & Kaimei, S (1997) Constraints on CD4 recovery post chemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90, 3789–3798.
30 Pierelli, L, Perillo, A, Ferrandina, G, et al. (2001) The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and M-CSF. Transfusion 41, 1577–1585.
31 Ferrandina, G, Pierelli, L, Perillo, A, et al. (2003) Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications. Clin Cancer Res 9, 195–200.
32 Wang, ZT, Du, Q, Xu, GJ, et al. (1997) Investigations on the protective action of Codonopsis pilosula (Dangshen) extract on experimentally-induced gastric ulcer in rats. Gen Pharmacol 28, 469–473.
33 Yang, T, Jia, M, Meng, J, et al. (2006) Immunomodulatory activity of polysaccharide isolated from Angelica sinensis. Int J Biol Macromol 39, 179–184.